Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Contingent Liabilities

    Back to Balance Sheet
BAL PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

BAL PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹17 Cr₹17 Cr₹16 Cr₹16 Cr₹13 Cr

What is the latest Contingent Liabilities ratio of BAL PHARMA ?

The latest Contingent Liabilities ratio of BAL PHARMA is ₹17 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹17 Cr
Mar2024₹17 Cr
Mar2023₹16 Cr
Mar2022₹16 Cr
Mar2021₹13 Cr

How is Contingent Liabilities of BAL PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹17 Cr
0.83
Mar2024 ₹17 Cr
3.16
Mar2023 ₹16 Cr
1.18
Mar2022 ₹16 Cr
25.01
Mar2021 ₹13 Cr -

Compare Contingent Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹101.8 Cr -4.4% -16% -27.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-4.4%

-16%

-27.1%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses